Companies in public sources

WuXi AppTec

Company documents and their place in the pharmaceutical supply chain.

Companies, institutions and data are cited as public industry context. These references do not imply partnership, endorsement, certification or a commercial relationship with our company.

Published company information

Use the linked sources to review the activities, dates and relationships explicitly described by this company.

Independent reference

This entry provides industry context. Mentioning a company or displaying its identity does not imply endorsement, affiliation or a commercial relationship with BLOPEP.

Sources and verification scope

Corporate disclosure · S08

WuXi AppTec expands global manufacturing capacity ↗

WuXi AppTec

Source details (original language)
Scope
Corporate statement: >100,000 L at end of 2025; expansion toward 130,000 L
Document section
SPPS reactor volume paragraph
Limitations
WuXi AppTec capacity only; target is not installed capacity. Not WuXi Biologics or Bolang.
Claim verification date
2026-09-09

Related reading